In The Biohacking/Human Performance News…
Novo Nordisk Is Testing Amycretin (World’s First Oral GLP-1 Medication). So Far (In Phase 1) The Results Look Very Promising Showing A 13% Weight Loss In 12 Weeks.
Continuous Glucose Monitors (CGM'S) - Useful or Not for Healthy Individuals?
Watch To Discover If CGM'S Are Viable Biohacking Tools Leading To Better Health
In The Biohacking/Human Performance News…
Resource Of The Week…
Biohacker Bulletin
Authors
Jim O'Connor
Recent Posts
Share this post